Login

Orchard Therapeutics plc SEC Filings

Filed On Filing
14 Nov 2024 SC 13G/A
14 Nov 2024 SC 13G/A
14 Feb 2024 SC 13G
14 Feb 2024 SC 13G/A
12 Feb 2024 SC 13G/A
09 Feb 2024 SC 13G/A
08 Feb 2024 SC 13G/A
05 Feb 2024 15-12G
30 Jan 2024 EFFECT
30 Jan 2024 EFFECT
24 Jan 2024 Form 4: Secor Alicia, Director

Disposed of 151,000 Stock Option (Right to Buy) (Disposition to Issuer)

24 Jan 2024 Form 4: Geraghty James A, Director

Returned 44,391 shares to the issuer · Disposed of 151,000 Stock Option (Right to Buy) (Disposition to Issuer)

24 Jan 2024 Form 4: Thomas Frank E, See Remarks

Returned 92,081 shares to the issuer · Disposed of 2,240,460 Stock Option (Right to Buy) (Disposition to Issuer)

24 Jan 2024 Form 4: Rowland Charles A Jr, Director

Returned 12,294 shares to the issuer · Disposed of 151,000 Stock Option (Right to Buy) (Disposition to Issuer)

24 Jan 2024 Form 4: Beck Joanne T., Director

Returned 9,294 shares to the issuer · Disposed of 151,000 Stock Option (Right to Buy) (Disposition to Issuer)

24 Jan 2024 Form 4: Gaspar Bobby, Director

Returned 366,158 shares to the issuer · Disposed of 4,184,280 Stock Option (Right to Buy) (Disposition to Issuer)

24 Jan 2024 Form 4: Dunoyer Marc, Director

Returned 37,179 shares to the issuer · Disposed of 231,030 Stock Option (Right to Buy) (Disposition to Issuer)

24 Jan 2024 Form 4: Altschuler Steven, Director

Disposed of 151,000 Stock Option (Right to Buy) (Disposition to Issuer)

24 Jan 2024 Form 4: Curnutte John T, Director

Disposed of 151,000 Stock Option (Right to Buy) (Disposition to Issuer)

24 Jan 2024 S-8 POS

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support